The Composition Alteration of Respiratory Microbiota in Lung Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Gouvinhas C, De Mello RA, Oliveira D, Castro-Lopes JM, Castelo-Branco P, Dos Santos RS, et al. Lung cancer: a brief review of epidemiology and screening. Future Oncol. 2018;14(6):567–575. doi:10.2217/fon-2017-0486.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):23–34. doi:10.1016/S1470-2045(13)70546-1.
   PubMed Web of Science ®Google Scholar
• Zhuang H, Cheng L, Wang Y, Zhang YK, Zhao MF, Liang GD, et al. Dysbiosis of the gut microbiome in lung cancer. Front Cell Infect Microbiol. 2019;9:112. doi:10.3389/fcimb.2019.00112.
   PubMed Web of Science ®Google Scholar
• Mao Q, Jiang F, Yin R, Wang J, Xia W, Dong G, et al. Interplay between the lung microbiome and lung cancer. Cancer Lett. 2018;415:40–48. doi:10.1016/j.canlet.2017.11.036.
   PubMed Web of Science ®Google Scholar
• Maddi A, Sabharwal A, Violante T, Manuballa S, Genco R, Patnaik S, et al. The microbiome and lung cancer. J Thorac Dis. 2019;11(1):280–291. doi:10.21037/jtd.2018.12.88.
   PubMed Web of Science ®Google Scholar
• Mimee M, Citorik RJ, Lu TK. Microbiome therapeutics - advances and challenges. Adv Drug Deliv Rev. 2016;105(Pt A):44–54. doi:10.1016/j.addr.2016.04.032.
   PubMedGoogle Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi:10.1038/nature11234.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–812. doi:10.1038/nrc3610.
   PubMed Web of Science ®Google Scholar
• Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565(7741):600–605. doi:10.1038/s41586-019-0878-z.
   PubMed Web of Science ®Google Scholar
• Derosa L, Hellmann MD, Spaziano M, Halpenny D, Fidelle M, Rizvi H, et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol. 2018;29(6):1437–1444. doi:10.1093/annonc/mdy103.
   PubMed Web of Science ®Google Scholar
• Segal LN, Blaser MJ. A brave new world: the lung microbiota in an era of change. Annals Ats. 2014;11(1):S21–S27. doi:10.1513/AnnalsATS.201306-189MG.
   Google Scholar
• Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Annals Ats. 2015;12(6):821–830. doi:10.1513/AnnalsATS.201501-029OC.
   Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78(1):481–504. doi:10.1146/annurev-physiol-021115-105238.
   PubMedGoogle Scholar
• Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, et al. Sputum microbiome is associated with 1-year mortality after chronic obstructive pulmonary disease hospitalizations. Am J Respir Crit Care Med. 2019;199(10):1205–1213. doi:10.1164/rccm.201806-1135OC.
   PubMed Web of Science ®Google Scholar
• Perez-Losada M, Authelet KJ, Hoptay CE, Kwak C, Crandall KA, Freishtat RJ. Pediatric asthma comprises different phenotypic clusters with unique nasal microbiotas. Microbiome. 2018;6(1):179. doi:10.1186/s40168-018-0564-7.
   PubMedGoogle Scholar
• Sherrard LJ, Bell SC. Lower airway microbiota for ‘biomarker’ measurements of cystic fibrosis disease progression? Thorax. 2018;73(11):1001–1003. doi:10.1136/thoraxjnl-2018-212165.
   PubMed Web of Science ®Google Scholar
• Cameron SJS, Lewis KE, Huws SA, Hegarty MJ, Lewis PD, Pachebat JA, et al. Pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer. PLoS One. 2017;12(5):e0177062. doi:10.1371/journal.pone.0177062.
   PubMed Web of Science ®Google Scholar
• Hosgood HD, 3rd, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J, et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen. 2014;55(8):643–651. doi:10.1002/em.21878.
   PubMed Web of Science ®Google Scholar
• Jin J, Gan Y, Liu H, Wang Z, Yuan J, Deng T, et al. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: a multiple comparative study design with independent validation. Lung Cancer. 2019;136:129–135. doi:10.1016/j.lungcan.2019.08.022.
   PubMed Web of Science ®Google Scholar
• Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89–95. doi:10.1016/j.lungcan.2016.10.016.
   PubMed Web of Science ®Google Scholar
• Liu HX, Tao LL, Zhang J, Zhu YG, Zheng Y, Liu D, et al. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2018;142(4):769–778. doi:10.1002/ijc.31098.
   PubMed Web of Science ®Google Scholar
• Liu Y, O’Brien JL, Ajami NJ, Scheurer ME, Amirian ES, Armstrong G, et al. Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res. 2018;8(9):1775–1787.
   PubMed Web of Science ®Google Scholar
• Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med. 2018;198(9):1188–1198. doi:10.1164/rccm.201710-2118OC.
   PubMed Web of Science ®Google Scholar
• Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19(1):123. doi:10.1186/s13059-018-1501-1506.
   PubMedGoogle Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17(1):1–12. doi:10.1016/0197-2456(95)00134-4.
   PubMedGoogle Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute. [accessed 2020 Jan 19]. Available from: https://http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Wang B, Yao M, Lv L, Ling Z, Li L. The human microbiota in health and disease. Engineering. 2017;3(1):71–82. doi:10.1016/J.ENG.2017.01.008.
   Web of Science ®Google Scholar
• Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, et al. The human microbiome and cancer. Cancer Prev Res. 2017;10(4):226–234. doi:10.1158/1940-6207.CAPR-16-0249.
   PubMed Web of Science ®Google Scholar
• Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal microbiota promote lung cancer development via gammadelta T cells. Cell. 2019;176(5):998–1013.e16. doi:10.1016/j.cell.2018.12.040.
   PubMed Web of Science ®Google Scholar
• Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349–364. doi:10.3322/canjclin.51.6.349.
   PubMed Web of Science ®Google Scholar
• Mori G, Rampelli S, Orena BS, Rengucci C, De Maio G, Barbieri G, et al. Shifts of faecal microbiota during sporadic colorectal carcinogenesis. Sci Rep. 2018;8(1):10329. doi:10.1038/s41598-018-28671-9.
   PubMedGoogle Scholar
• Girao M, Ribeiro I, Ribeiro T, Azevedo IC, Pereira F, Urbatzka R, et al. Actinobacteria isolated from Laminaria ochroleuca: a source of new bioactive compounds. Front Microbiol. 2019;10:683. doi:10.3389/fmicb.2019.00683.
   PubMed Web of Science ®Google Scholar
• Ellmerich S, Scholler M, Duranton B, Gosse F, Galluser M, Klein JP, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis. 2000;21(4):753–756. doi:10.1093/carcin/21.4.753.
   PubMed Web of Science ®Google Scholar
• Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg. 2004;139(7):760–765. doi:10.1001/archsurg.139.7.760.
   PubMedGoogle Scholar
• Biarc J, Nguyen IS, Pini A, Gosse F, Richert S, Thierse D, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis. 2004;25(8):1477–1484. doi:10.1093/carcin/bgh091.
   PubMed Web of Science ®Google Scholar
• Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, et al. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer. 2003;107(4):681–682. doi:10.1002/ijc.11353.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 2010;107(25):11537–11542. doi:10.1073/pnas.1001261107.
   PubMed Web of Science ®Google Scholar
• Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci USA. 2011;108(36):14944–14949. doi:10.1073/pnas.1100959108.
   PubMed Web of Science ®Google Scholar
• Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403–416. doi:10.1158/2159-8290.CD-17-1134.
   PubMed Web of Science ®Google Scholar
• Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: a common factor in human diseases. Biomed Res Int. 2017;2017:1–7. doi:10.1155/2017/9351507.
   Web of Science ®Google Scholar
• Guan WJ, Yuan JJ, Li HM, Gao YH, Huang Y, Chen CL, et al. Proteobacteria community compositions correlate with bronchiectasis severity. Int J Tuberc Lung Dis. 2018;22(9):1095–1105. doi:10.5588/ijtld.18.0037.
   PubMed Web of Science ®Google Scholar
• Huang JY, Jian ZH, Nfor ON, Ku WY, Ko PC, Lung CC, et al. The effects of pulmonary diseases on histologic types of lung cancer in both sexes: a population-based study in Taiwan. BMC Cancer. 2015;15(1):834. doi:10.1186/s12885-015-1847-z.
   PubMedGoogle Scholar
• Stressmann FA, Rogers GB, Klem ER, Lilley AK, Donaldson SH, Daniels TW, et al. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol. 2011;49(1):281–291. doi:10.1128/JCM.01650-10.
   PubMed Web of Science ®Google Scholar
• Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, Caporaso NE, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17(1):163. doi:10.1186/s13059-016-1021-1.
   PubMedGoogle Scholar
• Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, et al. Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases. Cell Rep. 2018;24(13):3528–3538. doi:10.1016/j.celrep.2018.08.090.
   PubMed Web of Science ®Google Scholar
• Cheng M, Qian L, Shen G, Bian G, Xu T, Xu W, et al. Microbiota modulate tumoral immune surveillance in lung through a gammadeltaT17 immune cell-dependent mechanism. Cancer Res. 2014;74(15):4030–4041. doi:10.1158/0008-5472.CAN-13-2462.
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017;10(2):299–306. doi:10.1038/mi.2016.108.
   PubMed Web of Science ®Google Scholar
• Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019;7:e7502. doi:10.7717/peerj.7502.
   PubMed Web of Science ®Google Scholar
• Martinez-Guryn K, Leone V, Chang EB. Regional diversity of the gastrointestinal microbiome. Cell Host Microbe. 2019;26(3):314–324. doi:10.1016/j.chom.2019.08.011.
   PubMed Web of Science ®Google Scholar
• Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon JY, Bernalier-Donadille A, et al. Desired turbulence? Gut-lung axis, immunity, and lung cancer. J Oncol. 2017;2017:1–15. doi:10.15/2017/5035371.
   Google Scholar
• Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc. 2015;12Suppl 2:S150–S156. doi:10.1513/AnnalsATS.201503-133AW.
   Google Scholar
• Liu F, Li J, Guan Y, Lou Y, Chen H, Xu M, et al. Dysbiosis of the gut microbiome is associated with tumor biomarkers in lung cancer. Int J Biol Sci. 2019;15(11):2381–2392. doi:10.7150/ijbs.35980.
   PubMed Web of Science ®Google Scholar
• Fouhy F, Clooney AG, Stanton C, Claesson MJ, Cotter PD. 16S rRNA gene sequencing of mock microbial populations- impact of DNA extraction method, primer choice and sequencing platform. BMC Microbiol. 2016;16(1):123. doi:10.1186/s12866-016-0738-z.
   PubMed Web of Science ®Google Scholar
• Teng F, Darveekaran Nair SS, Zhu P, Li S, Huang S, Li X, et al. Impact of DNA extraction method and targeted 16S-rRNA hypervariable region on oral microbiota profiling. Sci Rep. 2018;8(1):16321. doi:10.1038/s41598-018-34294-x.
   PubMedGoogle Scholar
• Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469(4):967–977. doi:10.1016/j.bbrc.2015.12.083.
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, et al. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol. 2014;52(10):3605–3613. doi:10.1128/JCM.01028-14.
   PubMed Web of Science ®Google Scholar
• Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–1633.e6. doi:10.1053/j.gastro.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Staley C, Kaiser T, Beura LK, Hamilton MJ, Weingarden AR, Bobr A, et al. Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning. Microbiome. 2017;5(1):87. doi:10.1186/s40168-017-0306-2.
   PubMed Web of Science ®Google Scholar
• De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397. doi:10.1126/scitranslmed.aaf6397.
   PubMed Web of Science ®Google Scholar
• DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc. 2009;4(7):1064–1072. doi:10.1038/nprot.2009.95.
   PubMed Web of Science ®Google Scholar